190 related articles for article (PubMed ID: 34976196)
1. A transcriptional biosensor to monitor single cancer cell therapeutic responses by bioluminescence microscopy.
Champagne A; Jain P; Vélot L; Riopel J; Lefebvre V; Neveu B; Pouliot F
Theranostics; 2022; 12(2):474-492. PubMed ID: 34976196
[TBL] [Abstract][Full Text] [Related]
2. An Extracellular Matrix Overlay Model for Bioluminescence Microscopy to Measure Single-Cell Heterogeneous Responses to Antiandrogens in Prostate Cancer Cells.
Champagne A; Chebra I; Jain P; Ringuette Goulet C; Lauzier A; Guyon A; Neveu B; Pouliot F
Biosensors (Basel); 2024 Apr; 14(4):. PubMed ID: 38667168
[TBL] [Abstract][Full Text] [Related]
3. A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer.
Neveu B; Jain P; Têtu B; Wu L; Fradet Y; Pouliot F
Oncotarget; 2016 Jan; 7(2):1300-10. PubMed ID: 26594800
[TBL] [Abstract][Full Text] [Related]
4.
Özgür E; Celik AI; Darendeliler E; Gezer U
Anticancer Res; 2017 Jul; 37(7):3631-3637. PubMed ID: 28668854
[TBL] [Abstract][Full Text] [Related]
5. Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response.
Ylitalo EB; Thysell E; Jernberg E; Lundholm M; Crnalic S; Egevad L; Stattin P; Widmark A; Bergh A; Wikström P
Eur Urol; 2017 May; 71(5):776-787. PubMed ID: 27497761
[TBL] [Abstract][Full Text] [Related]
6. Development of a Transcriptional Amplification System Based on the PEG3 Promoter to Target Androgen Receptor-Positive and -Negative Prostate Cancer Cells.
Jain P; Clermont PL; Desmeules F; Zoubeidi A; Neveu B; Pouliot F
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626088
[TBL] [Abstract][Full Text] [Related]
7. Comparative Assessment of Efficacies Between 2 Alternative Therapeutic Sequences With Novel Androgen Receptor-Axis-Targeted Agents in Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer.
Miyake H; Hara T; Tamura K; Sugiyama T; Furuse H; Ozono S; Fujisawa M
Clin Genitourin Cancer; 2017 Aug; 15(4):e591-e597. PubMed ID: 28063845
[TBL] [Abstract][Full Text] [Related]
8. A luciferase transgenic mouse model: visualization of prostate development and its androgen responsiveness in live animals.
Hsieh CL; Xie Z; Liu ZY; Green JE; Martin WD; Datta MW; Yeung F; Pan D; Chung LW
J Mol Endocrinol; 2005 Oct; 35(2):293-304. PubMed ID: 16216910
[TBL] [Abstract][Full Text] [Related]
9. Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer.
Sato M; Johnson M; Zhang L; Gambhir SS; Carey M; Wu L
Clin Cancer Res; 2005 May; 11(10):3743-9. PubMed ID: 15897571
[TBL] [Abstract][Full Text] [Related]
10. Impact of Prior Use of an Androgen Receptor-Axis-Targeted (ARAT) Agent With or Without Subsequent Taxane Therapy on the Efficacy of Another ARAT Agent in Patients With Metastatic Castration-Resistant Prostate Cancer.
Miyake H; Hara T; Ozono S; Fujisawa M
Clin Genitourin Cancer; 2017 Apr; 15(2):e217-e222. PubMed ID: 27522450
[TBL] [Abstract][Full Text] [Related]
11. Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cells.
Dehm SM; Tindall DJ
J Biol Chem; 2006 Sep; 281(38):27882-93. PubMed ID: 16870607
[TBL] [Abstract][Full Text] [Related]
12. Repression of cell proliferation and androgen receptor activity in prostate cancer cells by 2'-hydroxyflavanone.
Ofude M; Mizokami A; Kumaki M; Izumi K; Konaka H; Kadono Y; Kitagawa Y; Shin M; Zhang J; Keller ET; Namiki M
Anticancer Res; 2013 Oct; 33(10):4453-61. PubMed ID: 24123015
[TBL] [Abstract][Full Text] [Related]
13. PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine.
Rigau M; Morote J; Mir MC; Ballesteros C; Ortega I; Sanchez A; Colás E; Garcia M; Ruiz A; Abal M; Planas J; Reventós J; Doll A
Prostate; 2010 Dec; 70(16):1760-7. PubMed ID: 20672322
[TBL] [Abstract][Full Text] [Related]
14. KLK3, PCA3, and TMPRSS2-ERG expression in the peripheral blood mononuclear cell fraction from castration-resistant prostate cancer patients and response to docetaxel treatment.
Dijkstra S; Leyten GH; Jannink SA; de Jong H; Mulders PF; van Oort IM; Schalken JA
Prostate; 2014 Sep; 74(12):1222-30. PubMed ID: 25043536
[TBL] [Abstract][Full Text] [Related]
15. Earlier use of androgen receptor-axis-targeted drugs may improve overall survival in patients with non-metastatic castration-resistant prostate cancer.
Mori K; Kimura T; Ito K; Onuma H; Tanaka M; Matsuura T; Kurokawa G; Iwatani K; Inaba Y; Sakanaka K; Sasaki H; Miki J; Shimomura T; Miki K; Egawa S
Prostate; 2018 Jul; 78(10):766-772. PubMed ID: 29635810
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9
Wang R; Sun Y; Li L; Niu Y; Lin W; Lin C; Antonarakis ES; Luo J; Yeh S; Chang C
Eur Urol; 2017 Nov; 72(5):835-844. PubMed ID: 28528814
[TBL] [Abstract][Full Text] [Related]
17. FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription.
Liu Y; Liu Y; Yuan B; Yin L; Peng Y; Yu X; Zhou W; Gong Z; Liu J; He L; Li X
Oncotarget; 2017 Mar; 8(10):17027-17037. PubMed ID: 28199985
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer.
Saeed K; Rahkama V; Eldfors S; Bychkov D; Mpindi JP; Yadav B; Paavolainen L; Aittokallio T; Heckman C; Wennerberg K; Peehl DM; Horvath P; Mirtti T; Rannikko A; Kallioniemi O; Östling P; Af Hällström TM
Eur Urol; 2017 Mar; 71(3):319-327. PubMed ID: 27160946
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor axis-targeted agents are not superior to conventional hormonal therapy for treatment of metastatic prostate cancer.
Wada A; Narita M; Nagasawa M; Kusaba T; Kubota S; Yoshida T; Johnin K; Kawauchi A; Kageyama S
Oncol Lett; 2022 Oct; 24(4):333. PubMed ID: 36039059
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive imaging of a transgenic mouse model using a prostate-specific two-step transcriptional amplification strategy.
Iyer M; Salazar FB; Lewis X; Zhang L; Wu L; Carey M; Gambhir SS
Transgenic Res; 2005 Feb; 14(1):47-55. PubMed ID: 15865048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
